Guangxi Wuzhou Zhongheng Group Co.,Ltd

600252

CNE0000015F9

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-05 pm EDT			5-day change	1st Jan Change
2.46 ^CNY	+0.82%		+6.96%	-1.99%

Apr. 29	Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.	CI

Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index

June 20, 2022 at 12:00 am EDT

Latest news about Guangxi Wuzhou Zhongheng Group Co.,Ltd

Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.	Apr. 16	CI
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.	Apr. 08	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	Mar. 18	MT
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test	Nov. 10	MT
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors	Nov. 09	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index	23-09-18	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index	23-09-18	CI
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug	23-09-15	MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy	23-08-17	MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended	23-01-24	MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index	22-06-20	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index	22-06-13	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-17	CI
Beibu Gulf Property & Casualty Insurance Co.,Ltd. announced that it expects to receive CNY 450 million in funding from Guangxi Wuzhou Zhongheng Group Co.,Ltd	21-11-21	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI

Chart Guangxi Wuzhou Zhongheng Group Co.,Ltd

Duration

Period

Chart Guangxi Wuzhou Zhongheng Group Co.,Ltd

More charts

GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture of pharmaceuticals and food production. The Company's pharmaceuticals include cardiovascular drugs, medicine for bruises, gynecology medication and other general drugs. The Company also provides Chinese herbal jelly products, Chinese herbal beverages and others. The Company is also engaged in the development of real estate, including the development and sales of commercial housings and stores. The Company mainly conducts its businesses within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD	-1.99%	1.16B
ELI LILLY AND COMPANY	+31.52%	662B
NOVO NORDISK A/S	+21.96%	546B
JOHNSON & JOHNSON	-5.21%	359B
MERCK & CO., INC.	+17.02%	323B
ABBVIE INC.	+5.01%	289B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.81%	198B
ROCHE HOLDING AG	-10.63%	194B
AMGEN INC.	+3.98%	167B

Other Pharmaceuticals